Keywords: icagen, start, trials, drugs, modulate, activity, ion

ICAgen To Start Trials Of Three Drugs In 1999

Article | 25 November 1998

Print This

Drugs which modulate the activity of ion channels already represent a $5billion-plus market worldwide, and feature mainstay medicines such as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in